Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice
Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, so by the time a tumor takes hold, it's often already shiel
Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, so by the time a tumor takes hold, it's often already shiel This story matters for Science & Discovery readers tracking inventors. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InventorsNews curates and briefs the science & discovery stories that matter. Our editorial policy →